Abstract
The use of platelet rich plasma is becoming popularised as a treatment for the aging face. In an attempt to assess the quality of evidence supporting this treatment for facial rejuvenation, a systematic review of randomised controlled trials was conducted. All trials were included until February 2016. The review failed to identify any clinical studies meeting the inclusion criteria. The efficacy, short and long-term safety of platelet rich plasma for facial rejuvenation has not been demonstrated. The appropriateness of delivering these treatments in the absence of these data is questionable.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Aesthetic Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
